BullFrog AI Holdings (BFRG) EBITDA (2022 - 2026)
BullFrog AI Holdings' (BFRG) quarterly EBITDA came in at -$1.4 million in Q2 2026, up 3.44% on a YoY basis from -$1.4 million in Q2 2025, and up 5.31% quarter-over-quarter from -$1.5 million in Q4 2025.
Analysis
BullFrog AI Holdings (BFRG) EBITDA (2022 - 2026) Analysis & Trends
BullFrog AI Holdings (BFRG) has reported EBITDA for 5 consecutive years, with -$1.4 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EBITDA rose 3.44% year-over-year to -$1.4 million; the trailing twelve-month figure through Jun 2026 stood at -$6.0 million (up 16.27% YoY), and the FY2025 full-year result was -$6.6 million, up 8.87% from the prior year.
- EBITDA rose to -$1.4 million in Q2 2026 per BFRG's latest filing, from -$1.5 million in the prior quarter.
- Across five years, EBITDA topped out at -$550251.0 in Q1 2022 and bottomed at -$2.1 million in Q1 2025.
- Historically, EBITDA has averaged -$1.4 million across 5 years, with a median of -$1.5 million in 2025.
- The sharpest annual moves came in 2023 and 2025: EBITDA sank 129.1% in 2023, then increased 15.27% in 2025.
- Over 5 years, EBITDA stood at -$583043.0 in 2022, then tumbled by 129.1% to -$1.3 million in 2023, then plunged by 32.42% to -$1.8 million in 2024, then increased by 15.27% to -$1.5 million in 2025, then climbed by 5.31% to -$1.4 million in 2026.
- According to Business Quant data, EBITDA over the past three periods registered -$1.4 million, -$1.5 million, and -$1.6 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 3.51 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | -10.39 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 1.25 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 1.29 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | 493.00 Mn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | -815.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 231.44 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | -644.50 Mn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | -1.55 Mn |
| 10 | BullFrog AI Holdings | 9.27 Mn | 2.35 Mn | 106,899.00 | -1.42 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.42 Mn |
| Dec 31, 2025 | -1.50 Mn |
| Sep 30, 2025 | -1.57 Mn |
| Jun 30, 2025 | -1.47 Mn |
| Mar 31, 2025 | -2.06 Mn |
| Dec 31, 2024 | -1.77 Mn |
| Sep 30, 2024 | -1.82 Mn |
| Jun 30, 2024 | -1.68 Mn |
| Mar 31, 2024 | -1.97 Mn |
| Dec 31, 2023 | -1.34 Mn |
| Sep 30, 2023 | -1.30 Mn |
| Jun 30, 2023 | -1.54 Mn |
| Mar 31, 2023 | -1.19 Mn |
| Dec 31, 2022 | -583,043.00 |
| Sep 30, 2022 | -640,552.00 |
| Jun 30, 2022 | -681,955.00 |
| Mar 31, 2022 | -550,251.00 |